North America Ophthalmology Glaucoma Surgery Device Market by Type (Glaucoma Drainage Device, Implants & Stents), by End-user (Private Eye Clinics, Hospitals) - Analysis and Forecast To 2019

The North American ophthalmology glaucoma surgery devices market is estimated to grow at a CAGR of 7.8% from 2014 to 2019. Increasing aging population, increasing incidences of ocular disorders, and rising incidences of obesity and diabetes are the major factors driving the growth of this market. On the other hand, lack of awareness regarding eye disorders is the major factor that restrains the market growth.

Glaucoma is the second most common cause of blindness worldwide, and the leading cause of bilateral, irreversible blindness. It is characterized by the relatively high intraocular pressure (IOP) as a result of impaired drainage of a fluid, known as aqueous humor, from the eye. Currently, the approved treatments for glaucoma include a pharmaceutical drug, glaucoma laser therapies, and surgical procedures. It is estimated that by 2020, 11 million individuals will be blind due to glaucoma and around 10% of the people suffering from eye disorders will experience loss of vision in spite of proper treatment.

The U.S. is the leading country for ophthalmology glaucoma surgery devices market in North America with a market share of 90.0% in 2014, followed by Canada.

The report includes in-depth market share analysis, by revenue, of the leading market players. These numbers are arrived at, based on key facts, annual financial information from SEC filings, annual reports and interviews with industry experts and key opinion leaders, such as CEOs, directors, and marketing executives.

The key players in the North American ophthalmology glaucoma surgery device market are Abbott Laboratories (U.S.), Alcon, Inc. (Switzerland), Carl Zeiss Meditec AG (Germany), Nidek Co., Ltd. (U.S.), Lumenis Ltd. (Israel), Ellex Medical Lasers Ltd. (Australia), and IRIDEX Corporation (U.S.).

Table of Contents

1 Introduction (Page No. - 12)
    1.1 Objectives of the Study
    1.2 Market Segmentation & Coverage
    1.3 Stakeholders

2 Research Methodology (Page No. - 14)
    2.1 Integrated Ecosystem of Ophthalmology Glaucoma Surgery Devices Market
    2.2 Arriving at the Ophthalmology Glaucoma Surgery Devices Market Size
           2.2.1 Top-Down Approach
           2.2.2 Bottom-Up Approach
           2.2.3 Macro Indicator-Based Approach
    2.3 Assumptions

3 Executive Summary (Page No. - 21)

4 Market Overview (Page No. - 23)
    4.1 Introduction
    4.2 Ophthalmology Glaucoma Surgery Devices Market: Comparison With Parent Market
    4.3 Market Drivers and Inhibitors
    4.4 Key Market Dynamics

5 North America: Ophthalmology Surgery Devices Market, By Type (Page No. - 27)
    5.1 Introduction
    5.2 North America Ophthalmology Glaucoma Drainage Devices Market, By Geography
    5.3 North America Ophthalmology Glaucoma Implants & Stents Market, By Geography
    5.4 North America Ophthalmology Glaucoma Laser Market, By Geography
    5.5 North America Ophthalmology Glaucoma Systems Market, By Geography

6 North America: Ophthalmology Surgery Devices Market, By End-User (Page No. - 33)
    6.1 Introduction
    6.2 North America Ophthalmology Glaucoma Surgery Devices Market in Private Eye Clinic, By Geography
    6.3 North America Ophthalmology Glaucoma Surgery Devices Market in Hospital, By Geography

7 North America: Ophthalmology Surgery Devices Market, By Geography (Page No. - 37)
    7.1 Introduction
    7.2 U.S. Ophthalmology Glaucoma Surgery Devices Market
           7.2.1 U.S. Ophthalmology Glaucoma Surgery Devices Market, By Type
           7.2.2 U.S. Ophthalmology Glaucoma Surgery Devices Market, By End-User
    7.3 Canada Ophthalmology Glaucoma Surgery Devices Market
           7.3.1 Canada Ophthalmology Glaucoma Surgery Devices Market, By Type
           7.3.2 Canada Ophthalmology Glaucoma Surgery Devices Market, By End-User
    7.4 Mexico Ophthalmology Glaucoma Surgery Devices Market
           7.4.1 Mexico Ophthalmology Glaucoma Surgery Devices Market, By Type
           7.4.2 Mexico Ophthalmology Glaucoma Surgery Devices Market, By End-User

8 North America: Ophthalmology Surgery Devices Market: Competitive Landscape (Page No. -

49)
    8.1 North America Ophthalmology Glaucoma Surgery Devices Market, Company Share Analysis
    8.2 Mergers & Acquisitions
    8.3 Expansions
    8.4 Joint Ventures/Collaborations
    8.5 New Technology/Product Development

9 North America: Ophthalmology Surgery Devices Market, By Company (Page No. - 53)
(Overview, Financials, Products & Services, Strategy, and Developments)*
    9.1 Alcon, Inc.
    9.2 Abbott Laboratories
    9.3 Carl Zeiss Meditec AG
    9.4 Ellex Medical Lasers Ltd.
    9.5 Lumenis Ltd.
    9.6 Iridex Corporation
    9.7 Ioptima Ltd.
    9.8 Nidek Co., Ltd.
*Details on Overview, Financials, Product & Services, Strategy, and Developments Might Not be Captured in Case of Unlisted Company

10 Appendix (Page No. - 74)
     10.1 Customization Options
             10.1.1 Product Analysis
             10.1.2 Surgeons/Physicians Perception Analysis
             10.1.3 Brand/Product Perception Matrix
     10.2 Related Reports
     10.3 Introducing RT: Real Time Market Intelligence
             10.3.1 RT Snapshots

List of Tables (37 Tables)

Table 1 Ophthalmology Glaucoma Surgery Devices Peer Market Size, 2014 (USD MN)
Table 2 Ophthalmology Glaucoma Surgery Devices Market: Macro Indicator, By Geography, 2014 (USD MN)
Table 3 North America Ophthalmology Glaucoma Surgery Devices Market: Comparison With Parent Market, 2013-2019 (USD MN)
Table 4 North America Ophthalmology Glaucoma Surgery Devices Market: Drivers and Inhibitors
Table 5 North America Ophthalmology Glaucoma Surgery Devices Market, By Types, 2013-2019 (USD MN)
Table 6 North America Ophthalmology Glaucoma Surgery Devices Market, By End-User, 2013-2019 (USD MN)
Table 7 North America Ophthalmology Glaucoma Surgery Devices Market, By Geography, 2013-2019 (USD MN)
Table 8 North America Ophthalmology Glaucoma Surgery Devices Market, By Type, 2013-2019 (USD MN)
Table 9 North America Ophthalmology Glaucoma Drainage Devices Market, By Geography, 2013-2019 (USD MN)
Table 10 North America Ophthalmology Glaucoma Implants & Stents Market, By Geography, 2013-2019 (USD MN)
Table 11 North America Ophthalmology Glaucoma Laser Market, By Geography, 2013-2019 (USD MN)
Table 12 North America Ophthalmology Glaucoma Systems Market, By Geography, 2013-2019 (USD MN)
Table 13 North America Ophthalmology Glaucoma Surgery Devices Market, By End-User, 2013-2019 (USD MN)
Table 14 North America Ophthalmology Glaucoma Surgery Devices Market in Private Eye Clinic, By Geography, 2013-2019 (USD MN)
Table 15 North America Ophthalmology Glaucoma Surgery Devices Market in Hospital, By Geography, 2013-2019 (USD MN)
Table 16 North America Ophthalmology Glaucoma Surgery Devices Market, By Geography, 2013-2019 (USD MN)
Table 17 U.S. Ophthalmology Glaucoma Surgery Devices Market, By Type, 2013-2019 (USD MN)
Table 18 U.S. Ophthalmology Glaucoma Surgery Devices Market, By End-User, 2013-2019 (USD MN)
Table 19 Canada Ophthalmology Glaucoma Surgery Devices Market, By Type, 2013-2019 (USD MN)
Table 20 Canada Ophthalmology Glaucoma Surgery Devices Market, By End-User, 2013-2019 (USD MN)
Table 21 Mexico Ophthalmology Glaucoma Surgery Devices Market, By Type, 2013-2019 (USD MN)
Table 22 Mexico Ophthalmology Glaucoma Surgery Devices Market, By End-User, 2013-2019 (USD MN)
Table 23 North America Ophthalmology Glaucoma Surgery Devices Market, Company Share Analysis, 2014 (%)
Table 24 Ophthalmology Glaucoma Surgery Devices Market: Mergers & Acquisitions
Table 25 Ophthalmology Glaucoma Surgery Devices Market: Expansions
Table 26 Ophthalmology Glaucoma Surgery Devices Market: Joint Ventures/Collaborations
Table 27 Ophthalmology Glaucoma Surgery Devices Market: New Technology/Product Development
Table 28 Abbott Laboratories: Key Operations Data, 2012-2014 (USD MN)
Table 29 Abbott Laboratories: Key Financials, 2012-2014 (USD MN)
Table 30 Carl Zeiss Meditec AG: Key Operations Data, 2012-2014 (USD MN)
Table 31 Carl Zeiss Meditec AG: Key Financials, 2012-2014 (USD MN)
Table 32 Ellex Medical Lasers Ltd.: Key Operations Data, 2012-2014 (USD MN)
Table 33 Ellex Medical Lasers Ltd.: Key Financials, 2012-2014 (USD MN)
Table 34 Lumenis Ltd.: Key Operations Data, 2011-2013 (USD MN)
Table 35 Lumenis Ltd.: Key Financials, 2011-2013 (USD MN)
Table 36 Iridex Corporation: Key Operations Data, 2011-2013 (USD MN)
Table 37 Iridex Corporation: Key Financials, 2011-2013 (USD MN)

List of Figures (36 Figures)

Figure 1 Ophthalmology Glaucoma Surgery Devices Market: Segmentation & Coverage
Figure 2 Ophthalmology Glaucoma Surgery Devices Market: Integrated Ecosystem
Figure 3 Research Methodology
Figure 4 Top-Down Approach
Figure 5 Bottom-Up Approach
Figure 6 Macro Indicator-Based Approach
Figure 7 Ophthalmology Glaucoma Surgery Devices Market Snapshot, 2014
Figure 8 North America Ophthalmology Glaucoma Surgery Devices Market: Comparison With Parent Market
Figure 9 Geographic Analysis: North America Ophthalmology Glaucoma Surgery Devices Market, By Type, 2014 (USD MN)
Figure 10 North America Ophthalmology Glaucoma Surgery Devices Market, By Type, 2014-2019 (USD MN)
Figure 11 North America Ophthalmology Glaucoma Drainage Devices Market, By Geography, 2014-2019 (USD MN)
Figure 12 North America Ophthalmology Glaucoma Implants & Stents Market, By Geography, 2014-2019 (USD MN)
Figure 13 North America Ophthalmology Glaucoma Laser Market, By Geography, 2014-2019 (USD MN)
Figure 14 North America Ophthalmology Glaucoma Systems Market, By Geography, 2014-2019 (USD MN)
Figure 15 North America Ophthalmology Glaucoma Surgery Devices Market, By End-User, 2014-2019 (USD MN)
Figure 16 North America Ophthalmology Glaucoma Surgery Devices Market in Private Eye Clinic, By Geography, 2013-2019 (USD MN)
Figure 17 North America: Ophthalmology Glaucoma Surgery Device Market in Hospital, By Geography, 2013-2019 (USD MN)
Figure 18 North America Ophthalmology Glaucoma Surgery Devices Market: Growth Analysis, By Geography, 2014
Figure 19 U.S. Ophthalmology Glaucoma Surgery Devices Market Overview, 2014 & 2019 (%)
Figure 20 U.S. Ophthalmology Glaucoma Surgery Devices Market, By Type, 2014-2019 (USD MN)
Figure 21 U.S. Ophthalmology Glaucoma Surgery Devices Market, By End-User, 2014-2019 (USD MN)
Figure 22 U.S. Ophthalmology Glaucoma Devices Market Share, By Type, 2013-2019 (%)
Figure 23 Canada Ophthalmology Glaucoma Surgery Devices Market Overview, 2014 & 2019 (%)
Figure 24 Canada Ophthalmology Glaucoma Surgery Devices Market, By Type, 2014-2019 (USD MN)
Figure 25 Canada Ophthalmology Glaucoma Surgery Devices Market, By End-User, 2014-2019 (USD MN)
Figure 26 Canada Ophthalmology Glaucoma Devices Market Share, By Type, 2013-2019 (%)
Figure 27 Mexico Ophthalmology Glaucoma Surgery Devices Market Overview, 2014 & 2019 (%)
Figure 28 Mexico Ophthalmology Glaucoma Surgery Devices Market, By Type, 2014-2019 (USD MN)
Figure 29 Mexico Ophthalmology Glaucoma Surgery Devices Market, By End-User, 2014-2019 (USD MN)
Figure 30 Mexico Ophthalmology Glaucoma Devices Market Share, By Type, 2013-2019 (%)
Figure 31 North America Ophthalmology Glaucoma Surgery Devices Market, Company Share Analysis, 2014 (%)
Figure 32 Abbott Laboratories: Revenue Mix, 2014 (%)
Figure 33 Carl Zeiss Meditec AG: Revenue Mix, 2014 (%)
Figure 34 Ellex Medical Lasers Ltd.: Revenue Mix, 2014 (%)
Figure 35 Lumenis Ltd.: Revenue Mix, 2013 (%)
Figure 36 Iridex Corporation: Geographic Revenue Mix, 2013 (%)

The North American ophthalmology glaucoma surgery devices market has high growth potential and has witnessed extensive technological advancements since its establishment. Glaucoma is the second-most common cause of blindness worldwide, and the leading cause of bilateral, irreversible blindness. It is characterized by the relatively high intraocular pressure (IOP) as a result of impaired drainage of a fluid, known as aqueous humor, from the eye. Currently, the approved treatments for glaucoma include a pharmaceutical drug, glaucoma laser therapies, and surgical procedures. It is estimated that by 2020, 11 million individuals will be blind due to glaucoma and around 10% of the people suffering from eye disorders will experience loss of vision in spite of proper treatment.

The demand for technologically advanced and effective surgical equipment has led to the growth of the ophthalmology glaucoma surgery device market.

The North American ophthalmology glaucoma surgery device market was valued at $94.9 million in 2014 and is expected to reach $138.3 million by 2019, at a CAGR of 7.8% from 2014 to 2019. This market is driven by the increasing incidences of eye diseases, increased aging population, and rising prevalence of obesity and diabetes. However, lack of awareness among people regarding eye disorders and poor primary healthcare infrastructure are the major factors restraining the growth of this market.

Based on product types, the ophthalmology glaucoma surgery devices market in North America is segmented into glaucoma drainage devices (GDD), glaucoma implants and stents, glaucoma lasers, and glaucoma systems. The glaucoma drainage devices (GDD) segment held the largest market share of 56.1% in 2014.

Implants and stents segment is estimated to be the fastest-growing segment with a CAGR of 8.7% during the forecast period of 2014-2019.

The North American ophthalmology glaucoma surgery devices market is further segmented and forecast on the basis of major countries, including the U.S., Canada, and Mexico. The U.S. accounted for the largest market share of 90% in 2014 It was valued at $85.4 million in 2014 and is expected to reach to $124.7 million by 2019 with a CAGR of 7.9%.

The key players in the North American ophthalmology glaucoma surgery device market are Abbott Laboratories (U.S.), Alcon, Inc. (Switzerland), Carl Zeiss Meditec AG (Germany), Nidek Co., Ltd. (U.S.), Lumenis Ltd. (Israel), Ellex Medical Lasers Ltd. (Australia), and IRIDEX Corporation (U.S.).